Ikonisys Revenue
Biotechnology Research • 
Paris, Île-de-France, France • 21-50 Employees
Ikonisys revenue & valuation
| Annual revenue | $495,534 |
| Revenue per employee | $13,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,600,000 |
| Total funding | $1,434,400 |
Key Contacts at Ikonisys
Mario Crovetto
Ceo
Reza Jalali
Laboratory Director
Xiuzhong Wang
Director Of Imaging
Shawn Wang
Director Of Imaging
John Lappie
Director Of Information Technology
Eric Kershnar
Director Of Business Development
Robert Walat
Laboratory Director
Antti Seppo
Senior Director Of Biology
Rich Delaby
Regional Director
Company overview
| Headquarters | 62, Rue de Caumartin, Parigi, Ile-de-France 75009, FR |
| Phone number | +332037760795 |
| Website | |
| NAICS | 541714 |
| SIC | 382 |
| Keywords | Biotechnology, Cancer Diagnostics, CTC, Liquid Biopsy, Rare Cell Detection |
| Founded | 1999 |
| Employees | 21-50 |
| Socials |
Ikonisys Email Formats
Ikonisys uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@ikonisys.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@ikonisys.com | 100% |
About Ikonisys
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease. Through its breakthrough fluorescence microscopy platform, Ikonisys continues to develop a stream of oncology tests for a variety of cancers. At the center of the platform is the Ikoniscope20®, a robotic, high-throughput, microscopy system that provides a true “walk away” automated solution. In addition to providing high quality cell images, the platform analyzes the cells of interest, offering an interpretation of the analysis, to facilitate the quick, accurate reporting of the test result. In addition to automating traditional FISH-based tests, the rare cell detection and analysis capabilities of the platform, that facilitates the examination of large complex samples for the clinically relevant cells, make it particularly suitable for circulating tumor cell-based testing.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Ikonisys has 24 employees across 8 departments.
Departments
Number of employees
Funding Data
Explore Ikonisys's funding history, including investment rounds, total capital raised, and key backers.
Ikonisys Tech Stack
Discover the technologies and tools that power Ikonisys's digital infrastructure, from frameworks to analytics platforms.
Mobile frameworks
JavaScript libraries
Analytics
WordPress themes
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Spain
Belgium
Frequently asked questions
4.8
40,000 users
